Insider Selling: Alignment Healthcare (NASDAQ:ALHC) Insider Sells $393,217.16 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 21,118 shares of the stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total transaction of $393,217.16. Following the sale, the insider owned 148,687 shares in the company, valued at approximately $2,768,551.94. This trade represents a 12.44% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $18.44 on Friday. The company has a market cap of $3.77 billion, a P/E ratio of -1,842.16, a PEG ratio of 2.72 and a beta of 1.18. The business has a 50 day moving average of $20.95 and a two-hundred day moving average of $18.65. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87. The company has a quick ratio of 1.61, a current ratio of 1.71 and a debt-to-equity ratio of 1.80.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The business’s revenue was up 44.4% on a year-over-year basis. During the same quarter last year, the business posted ($0.16) EPS. As a group, analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ALHC. KeyCorp reaffirmed an “overweight” rating and issued a $28.00 price objective on shares of Alignment Healthcare in a report on Thursday, January 22nd. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a research note on Friday, January 30th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research report on Wednesday, January 21st. TD Cowen raised their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a research note on Friday, January 16th. Finally, JPMorgan Chase & Co. boosted their price objective on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a research report on Thursday, February 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Alignment Healthcare has an average rating of “Moderate Buy” and a consensus target price of $24.56.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 15,492,802 shares of the company’s stock worth $305,983,000 after acquiring an additional 1,524,218 shares in the last quarter. Wellington Management Group LLP raised its position in shares of Alignment Healthcare by 26.9% during the fourth quarter. Wellington Management Group LLP now owns 14,070,893 shares of the company’s stock worth $277,900,000 after purchasing an additional 2,981,166 shares during the period. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Alignment Healthcare by 0.6% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock valued at $249,715,000 after purchasing an additional 79,268 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Alignment Healthcare by 38.9% in the fourth quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock worth $122,501,000 after buying an additional 1,735,962 shares during the period. Finally, Hood River Capital Management LLC grew its holdings in shares of Alignment Healthcare by 6.0% during the second quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company’s stock valued at $77,243,000 after buying an additional 311,424 shares in the last quarter. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.